Found: 64
Select item for more details and to access through your institution.
Is YouTube a sufficient source of information on Sarcoidosis?
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02956-2
- By:
- Publication type:
- Article
Classifying Interstitial Lung Disease: Omics Are in the Air.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study.
- Published in:
- Respirology, 2022, v. 27, n. 7, p. 501, doi. 10.1111/resp.14262
- By:
- Publication type:
- Article
Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1321, doi. 10.3390/cells10061321
- By:
- Publication type:
- Article
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry.
- Published in:
- Pulmonary Circulation, 2023, v. 13, n. 4, p. 1, doi. 10.1002/pul2.12297
- By:
- Publication type:
- Article
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 1895, doi. 10.2147/PPA.S409767
- By:
- Publication type:
- Article
Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 512, doi. 10.1164/rccm.202402-0272LE
- By:
- Publication type:
- Article
Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
PP67 Validity Of A Questionnaire Assessing Patient Medication Experiences.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 6, p. 989, doi. 10.1513/AnnalsATS.202401-112RL
- By:
- Publication type:
- Article
Antacid Medication and Antireflux Surgery in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4397, doi. 10.1093/rheumatology/keac091
- By:
- Publication type:
- Article
Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2467, doi. 10.1093/rheumatology/keaa607
- By:
- Publication type:
- Article
Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population.
- Published in:
- Chronic Respiratory Disease, 2021, v. 18, p. 1, doi. 10.1177/14799731211031935
- By:
- Publication type:
- Article
Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire.
- Published in:
- Patient, 2019, v. 12, n. 1, p. 149, doi. 10.1007/s40271-018-0340-6
- By:
- Publication type:
- Article
Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
- Published in:
- Patient, 2017, v. 10, n. 5, p. 629, doi. 10.1007/s40271-017-0234-z
- By:
- Publication type:
- Article
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
How Informed Are German Patients with Pulmonary Sarcoidosis about Their Disease?
- Published in:
- Respiration, 2023, v. 102, n. 5, p. 361, doi. 10.1159/000529890
- By:
- Publication type:
- Article
The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study.
- Published in:
- Respiration, 2021, v. 100, n. 8, p. 780, doi. 10.1159/000516291
- By:
- Publication type:
- Article
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
- Published in:
- Respiration, 2020, v. 99, n. 1, p. 73, doi. 10.1159/000504763
- By:
- Publication type:
- Article
Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.
- Published in:
- Respiration, 2019, v. 97, n. 2, p. 173, doi. 10.1159/000495046
- By:
- Publication type:
- Article
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views.
- Published in:
- Respiration, 2018, v. 96, n. 6, p. 514, doi. 10.1159/000490667
- By:
- Publication type:
- Article
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis.
- Published in:
- Respiration, 2018, v. 95, n. 5, p. 317, doi. 10.1159/000486286
- By:
- Publication type:
- Article
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 7, p. 3392, doi. 10.1007/s12325-022-02145-x
- By:
- Publication type:
- Article
Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 4040, doi. 10.1007/s12325-021-01790-y
- By:
- Publication type:
- Article
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 7, p. 691, doi. 10.1007/s12325-015-0225-1
- By:
- Publication type:
- Article
The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02897-w
- By:
- Publication type:
- Article
Increased proportions of circulating PD-1<sup>+</sup> CD4<sup>+</sup> memory T cells and PD-1<sup>+</sup> regulatory T cells associate with good response to prednisone in pulmonary sarcoidosis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02833-y
- By:
- Publication type:
- Article
Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02575-3
- By:
- Publication type:
- Article
Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02336-4
- By:
- Publication type:
- Article
Educational aspects of rare and orphan lung diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Translation and validation of the King’s Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.
- Published in:
- Chronic Respiratory Disease, 2017, v. 14, n. 2, p. 140, doi. 10.1177/1479972316674425
- By:
- Publication type:
- Article
Optimizing quality of life in patients with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2017, v. 11, n. 3, p. 157, doi. 10.1177/1753465816686743
- By:
- Publication type:
- Article
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 9, p. 1084, doi. 10.1164/rccm.202106-1485OC
- By:
- Publication type:
- Article
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
- Published in:
- 2022
- By:
- Publication type:
- editorial
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ziritaxestat and Lung Function in Idiopathic Pulmonary Fibrosis—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 10, p. 973, doi. 10.1001/jama.2023.12640
- By:
- Publication type:
- Article
The flare of care for rare: per aspera ad astra for rare lung diseases!
- Published in:
- European Respiratory Review, 2023, v. 32, n. 167, p. 1, doi. 10.1183/16000617.0006-2023
- By:
- Publication type:
- Article
The world of rare interstitial lung diseases.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 167, p. 1, doi. 10.1183/16000617.0161-2022
- By:
- Publication type:
- Article
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?.
- Published in:
- European Respiratory Review, 2021, v. 30, n. 160, p. 1, doi. 10.1183/16000617.0026-2021
- By:
- Publication type:
- Article